Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

The Globe and Mail spoke with eight people whose pet’s health declined after taking Librela. Drugmaker Zoetis has responded ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Supreme Court dismisses plea mandating doctors to specify drug side effects, citing impracticality and existing regulations.

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

The Supreme Court on Thursday dismissed a plea seeking a direction to mandate medical professionals to specify to patients ...

Zealand Pharma A/S said moderate doses of its experimental weight-loss drug helped patients pare pounds with less nausea than ...

Neurogene stock collapsed, again, on Monday after the company scrapped the high dose of its experimental Rett syndrome ...